Can I read Nanocarriers for Cancer Nano-immunotherapy on EtoBox?

Nanocarriers for Cancer Nano-immunotherapy by Isra Rana; Jaeeun Oh; Juwon Baig; Jeong Hyun Moon; Sejin Son; Jutaek Nam is a Pharmacology, Toxicology and Pharmaceutics article available to read on EtoBox.

What is Nanocarriers for Cancer Nano-immunotherapy about?

The host immune system possesses an intrinsic ability to target and kill cancer cells in a specific and adaptable manner that can be further enhanced by cancer immunotherapy, which aims to train the immune system to boost the antitumor immune response. Several different categories of cancer immunotherapy have emerged as new standard cancer therapies in the clinic, including cancer vaccines, immune checkpoint inhibitors, adoptive T cell therapy, and oncolytic virus therapy. Despite the remarkable survival benefit for a subset of patients, the low response rate and immunotoxicity remain the major challenges for current cancer immunotherapy. Over the last few decades, nanomedicine has been intensively investigated with great enthusiasm, leading to marked advancements in nanoparticle platforms and nanoengineering technology. Advances in nanomedicine and immunotherapy have also led to the emergence of a nascent research field of nano-immunotherapy, which aims to realize the full therapeutic potential of immunotherapy with the aid of nanomedicine. In particular, nanocarriers present an exciting opportunity in immuno-oncology to boost the activity, increase specificity, decrease toxicity,

Who reads Nanocarriers for Cancer Nano-immunotherapy?

Author

Isra Rana; Jaeeun Oh; Juwon Baig; Jeong Hyun Moon; Sejin Son; Jutaek Nam

Publisher

Springer Science and Business Media LLC

Published

2022

Language

EN

Field

Pharmacology, Toxicology and Pharmaceutics (Life Sciences)